Fulgent Genetics, Inc. FLGT Therapeutic Development — Goodwill Purchase Accounting Adjustments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s therapeutic development — goodwill purchase accounting adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s therapeutic development — goodwill purchase accounting adjustments?
- Fulgent Genetics, Inc. (FLGT) reported therapeutic development — goodwill purchase accounting adjustments of -$2.73M in Q1 2026.
- What does therapeutic development — goodwill purchase accounting adjustments mean?
- Captures periodic adjustments made to the carrying value of goodwill following initial acquisition accounting within the therapeutic development segment. These adjustments often reflect changes in valuation assumptions or the resolution of contingencies related to business combinations.